Drug intelligence / Profile preview

JY05

Development stage
Unknown
Lead developer
Jiuyuan Gene Engineering
Modality
Peptides, Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Administration
Subcutaneous
01

Overview

JY05 is a biosimilar candidate of dulaglutide, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. Developed by Hangzhou Jiuyuan Genetic Biopharmaceutical (also known as Hangzhou Yuanda Biopharmaceutical), JY05 is a recombinant fusion protein consisting of two GLP-1 molecules linked to a human IgG4 Fc fragment. The drug acts by binding to and activating the GLP-1 receptor, which enhances glucose-dependent insulin secretion, suppresses inappropriate glucagon secretion, and slows gastric emptying. It is primarily being developed for the treatment of type 2 diabetes and is currently in Phase 1 clinical trials to demonstrate bioequivalence and safety compared to the reference product.

Other names
dulaglutide biosimilar
02

Targets

GLP1R (GLP-1R)FCGRT (Neonatal crystallizable fragment receptor)FcγR (Low affinity immunoglobulin gamma Fc region receptor II-c)

Beyond the preview

Go deeper on JY05.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JY05.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call